Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-5326 (Apilimod) in Rheumatoid Arthritis
NCT00642629Phase 2Completed
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apilimod in rheumatoid arthritis (RA), sponsored by Synta Pharmaceuticals Corp.. Started Dec 2005; status: completed.
02
Drugs
apilimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00642629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642629.